Implementing aid transparency in Sweden

whitePaper | November 9, 2019

The underlying driver of the ongoing US–China trade war is a race for global technological dominance. President Trump has raised a number of issues regarding trade with China – including the US’s trade deficit with China and the naming of China as a currency manipulator. But at the heart of the ongoing tariff escalation are China’s policies and practices regarding forced technology transfer, intellectual property theft and non-market distortions.

whitePaper | May 25, 2022

On 22 July 1994, then 29-year-old army lieutenant Yahya Abdul-Aziz Jemus Junkung Jammeh came to power through a military coup d’état – having ousted the democratically elected President Sir Dawda Kairaba Jawara. For 22 years, Yahya Jammeh ruled The Gambia with an iron fist. During his regime, extrajudicial killings, rape, torture, enforced disappearances, and numerous grievous human rights violations became part and parcel of his military Junta.

whitePaper | December 27, 2021

Government Financial & Operational Management Special Report Identifying the challenges that face your governmental entity is oftentimes the first step in helping position your government for future success. Are you able to balance the needs of your community while efficiently managing and reporting on the services you’re charged with providing?

whitePaper | February 2, 2022

The United Kingdom is an unparalleled success story – a multi-cultural, multi-national, multi-ethnic state with the world’s best broadcaster; a vibrantly creative arts sector; a National Health Service which guarantees care for every citizen; charities and voluntary groups which perform a million acts of kindness daily; globally renowned scientists extending the boundaries of knowledge every year; entrepreneurs developing the products and services which bring joy and jobs to so many; and millions of citizens whose kindness and compassion has been so powerfully displayed during the COVID-19 pandemic.

whitePaper | February 12, 2020

Both the U.S. Government and biopharmaceutical industry have been central engines for developing new medical treatments and cures, thereby lowering the effective price of better health for patients worldwide. The sector has done so by being both the world leader in these biopharmaceutical cures and treatments as well as the source of the returns that are required to fund new medical R&D investments.

whitePaper | July 4, 2022

Keeping a racecar running at peak performance for 24 hours straight is no easy feat. Every aspect of design, engineering, strategy, and performance is pushed to the limit. The process of finishing a race involves hundreds of team members working together round th